Determination of hydralazine with flow injection chemiluminescence sensor using molecularly imprinted polymer as recognition elementYAN XIONG; HOUJIANG ZHOU; ZHUJUN ZHANG et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 694-700, issn 0731-7085, 7 p.Article

ANTI-ACROLEIN TREATMENT IMPROVES BEHAVIORAL OUTCOME AND ALLEVIATES MYELIN DAMAGE IN EXPERIMENTAL AUTOIMMUNE ENCHEPHALOMYELITIS MOUSELEUNG, G; SUN, W; ZHENG, L et al.Neuroscience. 2011, Vol 173, pp 150-155, issn 0306-4522, 6 p.Article

Ex vivo human placental transfer and the vasoactive properties of hydralazineMAGEE, K. P; BAWDON, R. E.American journal of obstetrics and gynecology. 2000, Vol 182, Num 1, pp 167-169, issn 0002-9378, 1Article

Reactivation of tumor suppressor genes by the cardiovascular drugs Hydralazine and procainamide ad their potential use in cancer therapySEGURA-PACHECO, Blanca; TREJO-BECERRIL, Catalina; PEREZ-CARDENAS, Enrique et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1596-1603, issn 1078-0432, 8 p.Article

Hydralazine-induced cholangitisMYERS, J. L; AUGUR, N. A. JR.Gastroenterology (New York, NY. 1943). 1984, Vol 87, Num 5, pp 1185-1188, issn 0016-5085Article

Combination of thiazolidinedione and hydralazine suppresses proliferation and induces apoptosis by PPARγ up-expression in MDA-MB-231 cellsYING JIANG; YEQING HUANG; CHUN CHENG et al.Experimental and molecular pathology. 2011, Vol 91, Num 3, pp 768-774, issn 0014-4800, 7 p.Article

DNA methylation and autoimmune diseaseRICHARDSON, Bruce.Clinical immunology (Orlando, Fla. Print). 2003, Vol 109, Num 1, pp 72-79, issn 1521-6616, 8 p.Article

Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft functionPOLYAK, M. M. R; ARRINGTON, B. O; KAPUR, S et al.Transplantation. 2000, Vol 69, Num 1, pp 184-186, issn 0041-1337Article

Fulminating hydralazine-induced lupus pneumonitisBIRNBAUM, Belinda; SIDHU, Gurdip S; SMITH, Robert L et al.Arthritis care and research. 2006, Vol 55, Num 3, pp 501-506, issn 0893-7524, 6 p.Article

ETUDE SPECTROPHOTOMETRIQUE DE L'HYDRALAZINESOLOMONOVA SG; TURKEVICH MM; KURYINNA NV et al.1973; FARM. ZH., U.R.S.R.; S.S.S.R.; DA. 1973; VOL. 28; NO 1; PP. 42-44; ABS. ANGL. RUSSE; BIBL. 7 REF.Serial Issue

Hydralazine and Isosorbide Dinitrate in Heart Failure Historical Perspective, Mechanisms, and Future DirectionsCOLE, Robert T; KALOGEROPOULOS, Andreas P; GEORGIOPOULOU, Vasiliki V et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 21, pp 2414-2422, issn 0009-7322, 9 p.Article

Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivoHORSMAN, M. R; CHRISTENSEN, K. L; OVERGAARD, J et al.International journal of hyperthermia. 1989, Vol 5, Num 2, pp 123-136, issn 0265-6736, 14 p.Article

COMPARATIVE EVALUATION OF THE HYPOTENSIVE ACTIVITY OF TWO MAJOR METABOLITES OF HYDRALAZINE (1-HYDRAZINOPHTHALAZINE).MCLEAN AJ; HAEGELE KD; DU SOUICH P et al.1977; EUROP. J. DRUG METABOL. PHARMACOKINET.; FR.; DA. 1977; VOL. 2; NO 1; PP. 17-20; BIBL. 20 REF.Article

The African-American heart failure trial: Background, rationale and significanceTAYLOR, Anne L; COHN, Jay N; WORCEL, Manuel et al.Journal of the National Medical Association. 2002, Vol 94, Num 9, pp 762-769, issn 0027-9684, 8 p.Article

Hydralazine-induced fixed drug eruptionSEHGAL, V. N; GANGWANI, O. P.International journal of dermatology. 1986, Vol 25, Num 6, issn 0011-9059, 394Article

Separation and quantitation of hydralazine metabolites by high-performance liquid chromatographyLACAGNIN, L. B; COLBY, H. D; O'DONNELL, J. P et al.Journal of chromatography. 1986, Vol 377, pp 319-327, issn 0021-9673Article

Physicochemical study of the interaction of montmorillonite with hydralazine hydrochloride, a cardiovascular drugSANCHEZ-MARTIN, M. J; SANCHEZ-CAMAZANO, M; SAYALERO, M. L et al.Applied clay science. 1988, Vol 3, Num 1, pp 53-61, issn 0169-1317Article

The in vitro metabolism of hydralazineSTREETER, A. J; TIMBRELL, J. A.Drug metabolism and disposition. 1985, Vol 13, Num 2, pp 255-259, issn 0090-9556Article

Hydralazine therapy in chronic congestive heart failure: sustained central and regional hemodynamic responsesMAGORIEN, R. D; UNVERFERTH, D. V; LEIER, C. V et al.The American journal of medicine. 1984, Vol 77, Num 2, pp 267-274, issn 0002-9343Article

Inhibition of Nitric Oxide Synthases Abrogates Pregnancy-Induced Uterine Vascular Expansive RemodelingOSOL, George; BARRON, Carolyn; GOKINA, Natalia et al.Journal of vascular research. 2009, Vol 46, Num 5, pp 478-486, issn 1018-1172, 9 p.Article

Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive ratsRODRIGUES, Stephen F; DE OLIVEIRA, Maria A; DOS SANTOS, Rosangela A et al.European journal of pharmacology. 2008, Vol 589, Num 1-3, pp 206-214, issn 0014-2999, 9 p.Article

FLUORESCENCE OF HYDRALAZINE IN CONCENTRATED SULFURIC ACID = LA FLUORESCENCE DE L'HYDRALAZINE DANS L'ACIDE SULFURIQUE CONCENTRENAIK DV; DAVIS BR; MINNET KM et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 2; PP. 274-276; BIBL. 16 REF.Article

THE DETERMINATION OF HYDRALAZINE IN PLASMA BY GAS-LIQUID CHROMATOGRAPHY.JACK DB; BRECHBUHLER S; DEGEN PH et al.1975; J. CHROMATOGR.; NETHERL.; DA. 1975; VOL. 115; NO 1; PP. 87-92; BIBL. 7 REF.Article

METHODE POLAROGRAPHIQUE D'EVALUATION DE LA STABILITE DES SOLUTIONS AQUEUSES DE CHLORHYDRATE D'HYDRAZINO-1 PHTALAZINE (APRESOLINE) ET DE SULFATE DE DIHYDRAZINO-1,4 PHTALAZINEMODRAS Z.1972; CHEM. ANAL.; POLSKA; DA. 1972; VOL. 17; NO 5-6; PP. 1349-1353; ABS. ANGL.; BIBL. 16 REF.Serial Issue

Control of oxidative stress in microcirculation of spontaneously hypertensive ratsDELANO, F. A; BALETE, R; SCHMID-SCHÖNBEIN, G. W et al.American journal of physiology. Heart and circulatory physiology. 2005, Vol 57, Num 2, pp H805-H812, issn 0363-6135Article